Inozyme Pharma shares owned by Charles Schwab Investment Management
Quarter-by-quarter ownership of Inozyme Pharma (INZY) shares owned by Charles Schwab Investment Management
from 13F filings
Historical chart of Charles Schwab Investment Management investment in Inozyme Pharma
Tip: Access up to 7 years of quarterly data
All positions including Inozyme Pharma held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Inozyme Pharma by Charles Schwab Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $518k | 122k | 4.26 |
| 2023-09-30 | $395k | 94k | 4.20 |
| 2023-06-30 | $492k | 88k | 5.57 |
| 2023-03-31 | $95k | 17k | 5.73 |
| 2022-12-31 | $17k | 17k | 1.05 |
| 2022-09-30 | $45k | 17k | 2.72 |
| 2022-06-30 | $79k | 17k | 4.77 |
| 2022-03-31 | $125k | 31k | 4.10 |
| 2021-12-31 | $249k | 36k | 6.84 |
| 2021-09-30 | $423k | 36k | 11.61 |
| 2021-06-30 | $1.1M | 62k | 17.06 |
| 2021-03-31 | $1.2M | 60k | 19.82 |
| 2020-12-31 | $1.0M | 49k | 20.65 |
| 2020-09-30 | $1.3M | 48k | 26.30 |
More positions owned by Charles Schwab Investment Management
Home Depot (HD)
View all positions for Charles Schwab Investment Management